ALK and non-small cell lung carcinoma: One common example is the fusion of anaplastic lymphoma kinase (ALK) and echinoderm microtubule‐associated protein‐like 4 (EML4), found in  ̃ 2–9% of NSCLC patients (Soda et al, 2007).